Showing results (331-340 of 534) with videos related to
Sort By:
Pageof 54
European Journal of Pharmacology|February 21, 1977
Effect of metabolites of chlorpromazine on plasma prolactin levels in male ratsH Y Meltzer, V S Fang, M Simonovich, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1996
Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatmentH Y Meltzer, P A Thompson, M A Lee, et al.Advances in Experimental Medicine and Biology|January 1, 1975
Formation of aberrant neurotransmitters and its implication for alcohol addiction and intoxicationS G Alivisatos, R C AroraJournal of Lipid Research|January 1, 1972
Ceramide-like synthetic amides that inhibit cerebroside galactosidaseR C Arora, N S RadinAmerican Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 5, 2003
Adenosine A1 receptor activation reduces myocardial reperfusion effects on intrinsic cardiac nervous systemR C Arora, J A ArmourBiochemical and Biophysical Research Communications|July 16, 1985
Effect of reduced oxygen intermediates on sarcolemmal muscarinic receptors from canine heartR C Arora, M L HessActa Endocrinologica|June 1, 1982
Pattern of plasma progesterone, oestradiol-17 beta, luteinizing hormone and androgen in non-pregnant buffalo (Bubalus bubalis)R C Arora, R S PandeyJournal of Lipid Research|March 1, 1971
A simplified assay method for galactosyl ceramide beta-galactosidaseN S Radin, R C AroraEuropean Journal of Pharmacology|November 19, 1981
A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the ratR D Sturgeon, R G Fessler, S F London, et al.Behavioural Brain Research|December 15, 2021
Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophreniaL Rajagopal, C Ryan, A Elzokaky, et al.Pageof 54